Cancer Patient Equity Act of 2021
Official title: To facilitate the development of treatments for cancers, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Cancer Patient Equity Act of 2021
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
- Introduced in House Formatted Text PDF Formatted XML
Bodies those filers lobbied
Cite this page
U.S. Congress. (2026). H.R. 5377: Cancer Patient Equity Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5377/
"H.R. 5377: Cancer Patient Equity Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5377/.
H.R. 5377, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5377/.
[H.R. 5377: Cancer Patient Equity Act of 2021](https://openamerica.io/bill/117-HR-5377/)